Investigating some of the oral manifestations associated with neutropenia - a clinical cross-sectional study
- Conditions
- Oral HealthOral manifestations associated with neutropenia in patients with hematological malignancies undergoing chemotherapy
- Registration Number
- ISRCTN17585958
- Lead Sponsor
- Damascus University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
First group (patients with chemotherapy-induced neutropenia):
1. Patients diagnosed with hematological malignancy
2. Patients who received at least one cycle of chemotherapy
3. Patients developing neutropenia after chemotherapy, with an absolute neutrophil count (ANC) less than 1.5 x 10^9/L
Second group (patients without chemotherapy-induced neutropenia):
1. Patients diagnosed with hematological malignancy
2. The patient has received at least one cycle of chemotherapy
3. The patient does not present with post-chemotherapy neutropenia, and has an ANC greater than 1.5 x 10^9/
1. Patients receive radiation therapy as part of their treatment
2. The patient has been diagnosed with oral cancer
3. The patient is diagnosed with a non-hematological malignancy
4. The patient is diagnosed with diabetes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Oral manifestations measured using clinical and visual diagnosis at a single timepoint<br>2. Periodontal diseases measured using clinical and visual diagnosis at a single timepoint<br>3. Quality of life measured using a questionnaire that concentrates on different aspects of life as a result of neutropenia/chemotherapy at a single timepoint<br>
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures